Cardio-Oncology Summit 2026, Webinar Recording

Program Overview

This recording took place on February 20, 2026.
The NewYork-Presbyterian Cardio-Oncology Summit program will provide a comprehensive overview of the latest developments in the rapidly emerging field of cardio-oncology. The program consists of 7 unique sessions that will address key questions in the management of cardiac disease in patients with cancer as well as cancer survivors. NewYork-Presbyterian's Cardio-Oncology program has established new clinical pathways for Cardio-Oncology care from prevention of cardiac disease, to the management of acute and long-term cardiac toxicities. Sessions will consist of case based discussions, lectures and Q&A, presented by a multidisciplinary group of experts in the field of cardio-oncology from NewYork-Presbyterian, as well as invited guest faculty.

Learning Objectives

1. To identify cardiotoxicities associated with contemporary therapies for chronic lymphoid leukemia

2. To learn about recent advances in the treatment of immune checkpoint inhibitor myocarditis

3. To review current recommendations for management of advanced heart failure in patients with cancer

4. To understand optimal cardiac assessment prior to common cancer surgeries

5. To review contemporary diagnosis and management strategies of TTR and AL amyloidosis

6. To learn common drug interactions that arise during treatment of cardiac disease concurrently with cancer therapy

7. To review the latest guidelines regarding prevention and treatment of anthracycline and anti HER2 therapy related cardiotoxicity

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Columbia University. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE) and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physicians

Amedco LLC designates this live activity for a maximum of 7 AMA PRA Category 1 Credits for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses

Amedco LLC designates this activity for a maximum of 7 ANCC contact hours.

Agenda

Friday, February 20

8:15 AM - 8:55 AM

Registration & Vendor Exhibits

8:55 AM - 9:05 AM

Opening Remarks

Nir Uriel, MD, MSc

9:05 AM

SESSION 1: Advances in the Treatment of CLL Promising Outcomes with Novel Cardiotoxicity Profiles

Moderator: Jennifer Liu, MD Panel: Andrew Lipsky, MD, Jayant Raikhelkar, MD, Azita Talasaz, PharmD, PhD, Nicolas Palaskas, MD (MD Anderson Cancer Center)

9:05 AM - 9:15 AM

Case Presentations: A Case of BTK cardiotoxicity Lung Cancer Patients

9:15 AM - 10:15 AM

Contemporary Treatment of CLL

Andrew Lipsky, MD

9:30 AM - 9:45 AM

Cardiotoxicity of BTK inhibitors

Jayant Raikhelkar, MD

9:45 AM - 10:05 AM

Panel Discussion

10:05 AM

SESSION 2: Cardio-Oncology Meets Surgery: How to Risk Assess and Manage Patients Undergoing Cancer Surgery

Moderator: Michelle Bloom, MD Panel: James McKiernan, MD, Beatrice Dionigi, MD, Lisa Newman, MD

10:05 AM - 10:25 AM

Case Presentation: GU Surgery

10:25 AM - 10:45 AM

Case Presentation: Colon Cancer

10:45 AM - 11:05 AM

Case Presentation: Breast Cancer

11:05 AM

SESSION 3: Cardio-Protection During Cancer Therapy 2025: What’s New?

Moderator: Gagan Sahni (Mount Sinai) Panel: Jeff Cherng, MD, Meghna Trivedi, MD, Jennifer Liu, MD

11:05 AM - 11:15 AM

Case 1: Anthracycline Cardiotoxicity

11:15 AM - 11:25 AM

Updates in prevention of Anthracycline Cardiotoxicit

Jennifer Liu, MD

11:25 AM - 11:35 AM

Case 2: HER2 Cardiotoxicity

11:35 AM - 11:45 AM

Updates in Prevention and Management of HER2 Cardiotoxicity

Jennifer Liu, MD

11:45 AM - 12:00 PM

Panel Discussion

12:00 PM - 12:50 PM

Lunch & Vendor Exhibits

12:50 PM

KEYNOTE PRESENTATION

Moderator: Jayant Raikhelkar, MD Panel Members: Panel: Adam Mor, MD, Jo Ellen Rodgers, PharmD

12:50 PM - 1:00 PM

Case Presentation

1:00 PM - 1:30 PM

Keynote Lecture: ICI Myocarditis: Advances in Treatment and Unmet Needs for the Future

Nicolas Palaskas, MD MD Anderson Cancer Center

1:30 PM - 1:50 PM

Keynote Panel Discussion

1:50 PM

SESSION 4: Amyloid Session

Moderator: Mathew Maurer, MD

1:50 PM - 2:10 PM

Case 1: Navigating the Crossroads of ATTR and MGUS

Daniel McDonald, MD & Bilal Ansari, MD

2:10 PM - 3:10 PM

Case 2: Extracardiac Amyloidosis as a Window to Early Diagnosis of ATTR

Parag Goyal, MD & Nelson Barrera, MD

2:30 PM - 2:50 PM

Case 3: Management of Cardiac AL: From Diagnosis to Chemo and Beyond

Mathew Maurer, MD & Cornell Fellow (TBD)

2:50 PM - 3:05 PM

Break & Vendor Exhibits

3:05 PM

SESSION 5: Top 10 Drug Interactions in Cardio-Oncology

Moderator: Azita Talasaz, PharmD, PhD Panel Members: Jo Ellen Rodgers, PharmD

4:00 PM

SESSION 6: Advanced Cardio-Oncology

Moderator: Nir Uriel, MD, MSc Panel: Farhana Latif, MD, Gabriel Sayer, MD, David Majure, MD

5:00 PM

Closing Remarks

Gabriel Sayer, MD & Jayant Raikhelkar, MD

Speakers

Nir Uriel, MD, MSc - Course Director

Jayant Raikhelkar, MD - Course Director

Nicolas Palaskas, MD - Guest Faculty

No records found.

LOCATION

Vivian & Seymour Milstein Family Heart Center, 173 Fort Washington Avenue, New York, NY 10032

Location: Vivian & Seymour Milstein Family Heart Center, 173 Fort Washington Avenue, New York, NY 10032

DATE

February 20, 2026 - December 31, 2026

add to calendar

share with others

LOCATION

Vivian & Seymour Milstein Family Heart Center

New York, NY

Vivian & Seymour Milstein Family Heart Center, 173 Fort Washington Avenue, New York, NY 10032

ALREADY REGISTERED?

manage registration

resend confirmation email

GET GUIDE APP